Assessment of the humoral immune response and safety of reduced doses of influenza vaccine administered intradermally compared to intramuscular administration
Phase of Trial: Phase II
Latest Information Update: 17 Feb 2015
At a glance
- Drugs Influenza virus vaccine liposomal (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Berna Biotech
- 08 Jul 2009 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials.
- 02 Jun 2009 Influenza virus vaccine identified as influenza virus vaccine liposomal
- 22 Nov 2007 New trial record.